Breaking News Instant updates and real-time market news.

NTGR

Netgear

$31.42 /

-0.21 (-0.66%)

16:16
10/27/21
10/27
16:16
10/27/21
16:16

Netgear reports Q3 adjusted EPS 50c, consensus 41c

Reports Q3 revenue $290.2M, consensus $294.96M. Patrick Lo, Chairman and CEO of NETGEAR, commented, "We delivered third quarter topline revenue within our guidance and came in above guidance on non-GAAP operating margin, primarily due to the performance of our SMB business. Although SMB products remained significantly supply constrained, we achieved SMB revenue growth of 3.4% quarter over quarter and 33% growth year over year. On the CHP side, the consumer retail WiFi market grew 15% above 2019 levels, which is lower than our prior expectations."

  • 27

    Oct

NTGR Netgear
$31.42 /

-0.21 (-0.66%)

07/22/21 BWS Financial
Netgear price target lowered to $43 from $54 at BWS Financial
07/22/21 Raymond James
Netgear price target lowered to $42 from $48 at Raymond James
07/22/21 Deutsche Bank
Netgear price target lowered to $34 from $44 at Deutsche Bank
02/04/21 BWS Financial
Netgear price target raised to $58 from $45 at BWS Financial

TODAY'S FREE FLY STORIES

Hot Stocks
TransUnion pledges to reach net-zero scope 1, 2 greenhouse gas emissions by 2025 » 06:58
11/29/21
11/29
06:58
11/29/21
06:58
TRU

TransUnion

$111.34 /

-2.87 (-2.51%)

TransUnion announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRU TransUnion
$111.34 /

-2.87 (-2.51%)

TRU TransUnion
$111.34 /

-2.87 (-2.51%)

11/23/21 Atlantic Equities
Atlantic Equities upgrades TransUnion on 'lower than feared' dilution
11/23/21 Atlantic Equities
TransUnion upgraded to Overweight from Neutral at Atlantic Equities
09/14/21 Baird
TransUnion acquisition a good strategic fit, says Baird
08/17/21 Barclays
TransUnion price target raised to $140 from $130 at Barclays
TRU TransUnion
$111.34 /

-2.87 (-2.51%)

TRU TransUnion
$111.34 /

-2.87 (-2.51%)

Hot Stocks
SpringsWorks Therapeutics announces full enrollment of Phase 2b ReNeu trial » 06:57
11/29/21
11/29
06:57
11/29/21
06:57
SWTX

SpringsWorks Therapeutics

$68.47 /

-1.68 (-2.39%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
07/21/21 H.C. Wainwright
SpringsWorks price target raised to $136 from $124 at H.C. Wainwright
07/20/21 Goldman Sachs
SpringsWorks Therapeutics price target raised to $123 from $107 at Goldman Sachs
SWTX SpringsWorks Therapeutics
$68.47 /

-1.68 (-2.39%)

  • 02
    Mar
Initiation
Raymond James starts 'undisputed market leader' Cadre at Outperform » 06:56
11/29/21
11/29
06:56
11/29/21
06:56
CDRE

Cadre

$19.40 /

-0.1 (-0.51%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDRE Cadre
$19.40 /

-0.1 (-0.51%)

CDRE Cadre
$19.40 /

-0.1 (-0.51%)

06:30 Today Raymond James
Cadre initiated with an Outperform at Raymond James
05:31 Today B. Riley
Cadre initiated with a Buy at B. Riley
  • 04
    Nov
CDRE Cadre
$19.40 /

-0.1 (-0.51%)

Hot Stocks
Asensus Surgical announces Senhance Robotic System order from RZD » 06:56
11/29/21
11/29
06:56
11/29/21
06:56
ASXC

Asensus Surgical

$1.43 /

-0.04 (-2.72%)

Asensus Surgical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

09/29/21 H.C. Wainwright
H.C. Wainwright sees 'positive signals' for Asensus after Japan pact
05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

ASXC Asensus Surgical
$1.43 /

-0.04 (-2.72%)

Hot Stocks
Drive Shack to bring Puttery to Philadelphia's Fishtown neighborhood » 06:55
11/29/21
11/29
06:55
11/29/21
06:55
DS

Drive Shack

$2.02 /

-0.045 (-2.18%)

Drive Shack announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DS Drive Shack
$2.02 /

-0.045 (-2.18%)

DS Drive Shack
$2.02 /

-0.045 (-2.18%)

08/09/21 Craig-Hallum
Craig-Hallum bullish on Drive Shack after 'significant' Q2 beat
03/26/21 Craig-Hallum
Drive Shack initiated with a Buy at Craig-Hallum
03/12/21 BTIG
Drive Shack cost cuts should be 'largely permanent,' says BTIG
12/17/20 B. Riley Securities
Drive Shack price target raised to $5.50 from $4 at B. Riley Securities
DS Drive Shack
$2.02 /

-0.045 (-2.18%)

  • 29
    Jan
Hot Stocks
Becton Dickinson appoints Joseph Smith as chief scientific officer » 06:54
11/29/21
11/29
06:54
11/29/21
06:54
BDX

Becton Dickinson

$238.46 /

-6.01 (-2.46%)

Becton Dickinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

11/12/21 Piper Sandler
Becton Dickinson shares can move higher after investor day, says Piper Sandler
08/26/21 Piper Sandler
Becton Dickinson Covid test approval 'nice positive,' says Piper Sandler
08/06/21 JPMorgan
Becton Dickinson downgraded to Neutral at JPMorgan on 'muted' FY22 outlook
08/06/21 JPMorgan
Becton Dickinson downgraded to Neutral from Overweight at JPMorgan
BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

BDX Becton Dickinson
$238.46 /

-6.01 (-2.46%)

Hot Stocks
Karuna Therapeutics appoints Charmaine Lykins as CCO » 06:54
11/29/21
11/29
06:54
11/29/21
06:54
KRTX

Karuna Therapeutics

$129.78 /

-4.7 (-3.49%)

Karuna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

11/08/21 Oppenheimer
Karuna Therapeutics price target raised to $175 from $148 at Oppenheimer
11/05/21 Mizuho
Karuna Therapeutics price target raised to $182 from $150 at Mizuho
11/04/21 Stifel
Karuna Therapeutics price target raised to $185 from $154 at Stifel
09/30/21 JPMorgan
Karuna Therapeutics initiated with an Overweight at JPMorgan
KRTX Karuna Therapeutics
$129.78 /

-4.7 (-3.49%)

  • 10
    Nov
  • 02
    Mar
Hot Stocks
European Commission approves KEYTRUDA plus LENVIMA for endometrial carcinoma » 06:53
11/29/21
11/29
06:53
11/29/21
06:53
MRK

Merck

$78.65 /

-3.65 (-4.43%)

, ESALY

Eisai

$62.28 /

+0.14 (+0.23%)

Merck and Eisai announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

05:29 Today Citi
Merck downgraded to Neutral from Buy at Citi
11/24/21 Truist
Merck price target raised to $95 from $92 at Truist
11/18/21 BMO Capital
Merck initiated with a Market Perform at BMO Capital
11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
ESALY Eisai
$62.28 /

+0.14 (+0.23%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
MRK Merck
$78.65 /

-3.65 (-4.43%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

Downgrade
Amundi downgraded to Equal Weight from Overweight at Morgan Stanley » 06:53
11/29/21
11/29
06:53
11/29/21
06:53
AMDUF

Amundi

$90.53 /

+ (+0.00%)

, MNGPF

Man Group

$3.02 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMDUF Amundi
$90.53 /

+ (+0.00%)

07/12/21 Morgan Stanley
Amundi price target raised to EUR 89.60 from EUR 88.40 at Morgan Stanley
07/12/21 Berenberg
Amundi price target raised to EUR 88 from EUR 85 at Berenberg
07/01/21 Deutsche Bank
Amundi price target lowered to EUR 77 from EUR 79 at Deutsche Bank
02/17/21 RBC Capital
Amundi price target raised to EUR 77 from EUR 75 at RBC Capital
MNGPF Man Group
$3.02 /

+ (+0.00%)

10/21/21 UBS
Man Group price target raised to 260 GBp from 245 GBp at UBS
10/18/21 Morgan Stanley
Man Group price target raised to 275 GBp from 253 GBp at Morgan Stanley
10/14/21 JPMorgan
Man Group price target raised to 280 GBp from 270 GBp at JPMorgan
10/14/21 Barclays
Man Group price target raised to 235 GBp from 210 GBp at Barclays
Initiation
Claros Mortgage initiated with a Market Perform at Keefe Bruyette » 06:52
11/29/21
11/29
06:52
11/29/21
06:52
CMTG

Claros Mortgage

$16.97 /

-0.06 (-0.35%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMTG Claros Mortgage
$16.97 /

-0.06 (-0.35%)

06:35 Today UBS
Claros Mortgage initiated with a Neutral at UBS
06:35 Today JPMorgan
Claros Mortgage initiated with an Overweight at JPMorgan
06:34 Today JMP Securities
Claros Mortgage initiated with an Outperform at JMP Securities
  • 03
    Nov
CMTG Claros Mortgage
$16.97 /

-0.06 (-0.35%)

Hot Stocks
European Commission approves KEYTRUDA plus LENVIMA for advanced RCC » 06:50
11/29/21
11/29
06:50
11/29/21
06:50
MRK

Merck

$78.65 /

-3.65 (-4.43%)

, ESALY

Eisai

$62.28 /

+0.14 (+0.23%)

Merck and Eisai announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

05:29 Today Citi
Merck downgraded to Neutral from Buy at Citi
11/24/21 Truist
Merck price target raised to $95 from $92 at Truist
11/18/21 BMO Capital
Merck initiated with a Market Perform at BMO Capital
11/18/21 Stifel
Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel
ESALY Eisai
$62.28 /

+0.14 (+0.23%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
MRK Merck
$78.65 /

-3.65 (-4.43%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

ESALY Eisai
$62.28 /

+0.14 (+0.23%)

MRK Merck
$78.65 /

-3.65 (-4.43%)

Recommendations
Deutsche Bank keeps $90 target on Micron after 'mixed' channel checks » 06:49
11/29/21
11/29
06:49
11/29/21
06:49
MU

Micron

$83.22 /

-3.03 (-3.51%)

While DRAM spot prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$83.22 /

-3.03 (-3.51%)

MU Micron
$83.22 /

-3.03 (-3.51%)

11/23/21
Fly Intel: Top five analyst upgrades
11/23/21 Mizuho
Micron upgraded to Buy from Neutral at Mizuho
11/19/21 Evercore ISI
Micron, Lam Research added to Top Picks list at Evercore ISI
11/19/21 Citi
Citi opens 'positive catalyst watch' on Micron with DRAM correction ending
MU Micron
$83.22 /

-3.03 (-3.51%)

MU Micron
$83.22 /

-3.03 (-3.51%)

MU Micron
$83.22 /

-3.03 (-3.51%)

MU Micron
$83.22 /

-3.03 (-3.51%)

Upgrade
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight » 06:48
11/29/21
11/29
06:48
11/29/21
06:48
ADGI

Adagio Therapeutics

$25.06 /

+6.33 (+33.80%)

, LLY

Eli Lilly

$260.00 /

-2.03 (-0.77%)

, REGN

Regeneron

$644.18 /

-3.31 (-0.51%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

REGN Regeneron
$644.18 /

-3.31 (-0.51%)

ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

06:18 Today Morgan Stanley
Adagio Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
11/05/21 Stifel
Stifel sees 'zero change' to Adagio, AbCellera theses due to Pfizer data
10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
08/31/21
Fly Intel: Top five analyst initiations
LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
10/27/21 Mizuho
Eli Lilly price target lowered to $272 from $279 at Mizuho
10/11/21
Fly Intel: Top five analyst upgrades
REGN Regeneron
$644.18 /

-3.31 (-0.51%)

11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
11/05/21
Fly Intel: Top five analyst downgrades
ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

REGN Regeneron
$644.18 /

-3.31 (-0.51%)

  • 06
    Aug
LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

ADGI Adagio Therapeutics
$25.06 /

+6.33 (+33.80%)

LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

REGN Regeneron
$644.18 /

-3.31 (-0.51%)

LLY Eli Lilly
$260.00 /

-2.03 (-0.77%)

REGN Regeneron
$644.18 /

-3.31 (-0.51%)

Hot Stocks
Ault Global Holdings' TurnOnGreen to install commercial EV chargers at resort » 06:48
11/29/21
11/29
06:48
11/29/21
06:48
DPW

Ault Global Holdings

$1.80 /

-0.095 (-5.01%)

Ault Global Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DPW Ault Global Holdings
$1.80 /

-0.095 (-5.01%)

DPW Ault Global Holdings
$1.80 /

-0.095 (-5.01%)

DPW Ault Global Holdings
$1.80 /

-0.095 (-5.01%)

Hot Stocks
Ancora urges Berry Global to commit to review of strategic alternatives » 06:47
11/29/21
11/29
06:47
11/29/21
06:47
BERY

Berry Global

$66.49 /

+1.31 (+2.01%)

Ancora Holdings Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BERY Berry Global
$66.49 /

+1.31 (+2.01%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

11/24/21 Raymond James
Berry Global initiated with a Market Perform at Raymond James
11/22/21 Citi
Berry Global price target raised to $89 from $84 at Citi
10/12/21 Mizuho
Berry Global initiated with a Neutral at Mizuho
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
BERY Berry Global
$66.49 /

+1.31 (+2.01%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

BERY Berry Global
$66.49 /

+1.31 (+2.01%)

Initiation
Allbirds initiated with an Outperform at Baird » 06:45
11/29/21
11/29
06:45
11/29/21
06:45
BIRD

Allbirds

$19.75 /

-0.54 (-2.66%)

Baird analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIRD Allbirds
$19.75 /

-0.54 (-2.66%)

06:35 Today Morgan Stanley
Morgan Stanley starts Allbirds at Equal Weight on unclear profitability path
06:15 Today Cowen
Allbirds initiated with an Outperform at Cowen
06:15 Today Stifel
Allbirds initiated with a Buy at Stifel
06:14 Today Morgan Stanley
Allbirds initiated with an Equal Weight at Morgan Stanley
  • 03
    Nov
BIRD Allbirds
$19.75 /

-0.54 (-2.66%)

BIRD Allbirds
$19.75 /

-0.54 (-2.66%)

Hot Stocks
Seritage Growth announces amendment to senior secured term loan agreement » 06:44
11/29/21
11/29
06:44
11/29/21
06:44
SRG

Seritage Growth Properties

$14.88 /

-0.54 (-3.50%)

Seritage Growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRG Seritage Growth Properties
$14.88 /

-0.54 (-3.50%)

Upgrade
HeadHunter upgraded to Buy from Neutral at UBS » 06:43
11/29/21
11/29
06:43
11/29/21
06:43
HHR

HeadHunter

$51.85 /

-3.255 (-5.91%)

UBS upgraded HeadHunter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HHR HeadHunter
$51.85 /

-3.255 (-5.91%)

HHR HeadHunter
$51.85 /

-3.255 (-5.91%)

11/16/21 Credit Suisse
HeadHunter price target raised to $71 from $58 at Credit Suisse
03/19/21 Credit Suisse
HeadHunter price target raised to $43 from $29 at Credit Suisse
03/19/21 JPMorgan
HeadHunter upgraded to Neutral from Underweight at JPMorgan
03/15/21 Renaissance Capital
HeadHunter downgraded to Hold from Buy at Renaissance Capital
HHR HeadHunter
$51.85 /

-3.255 (-5.91%)

  • 03
    Jun
Hot Stocks
Sage Therapeutics to host Sage FutureCast webcast » 06:43
11/29/21
11/29
06:43
11/29/21
06:43
SAGE

Sage Therapeutics

$39.36 /

-0.66 (-1.65%)

Sage Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$39.36 /

-0.66 (-1.65%)

SAGE Sage Therapeutics
$39.36 /

-0.66 (-1.65%)

11/18/21 Mizuho
Sage Therapeutics price target lowered to $44 from $52 at Mizuho
11/03/21 H.C. Wainwright
Sage Therapeutics price target lowered to $55 from $80 at H.C. Wainwright
11/02/21 RBC Capital
Sage Therapeutics price target lowered to $48 from $52 at RBC Capital
11/02/21 Piper Sandler
Sage's change to CORAL trial increases odds of approval, says Piper Sandler
SAGE Sage Therapeutics
$39.36 /

-0.66 (-1.65%)

SAGE Sage Therapeutics
$39.36 /

-0.66 (-1.65%)

Initiation
Ecovyst initiated with a Neutral at Citi » 06:42
11/29/21
11/29
06:42
11/29/21
06:42
ECVT

Ecovyst

$9.86 /

-0.04 (-0.40%)

Citi initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

11/16/21 Deutsche Bank
Ecovyst price target lowered to $16 from $20 at Deutsche Bank
08/16/21 BMO Capital
Ecovyst initiated with an Outperform at BMO Capital
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

  • 19
    Nov
ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

ECVT Ecovyst
$9.86 /

-0.04 (-0.40%)

Earnings
Church & Dwight sees 2021 adjusted EPS $2.96, consensus $2.99 » 06:41
11/29/21
11/29
06:41
11/29/21
06:41
CHD

Church & Dwight

$91.76 /

-1.615 (-1.73%)

CEO Matthew Farrell said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

11/01/21 Jefferies
Newell Brands remains a top long idea, says Jefferies
10/20/21 Deutsche Bank
Church & Dwight price target lowered to $90 from $94 at Deutsche Bank
07/14/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
07/13/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

Upgrade
Citi upgrades Burlington, TJX on more optimistic off-price view » 06:41
11/29/21
11/29
06:41
11/29/21
06:41
BURL

Burlington Stores

$283.37 /

-7.46 (-2.57%)

, TJX

TJX

$69.30 /

-2.2 (-3.08%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$283.37 /

-7.46 (-2.57%)

TJX TJX
$69.30 /

-2.2 (-3.08%)

BURL Burlington Stores
$283.37 /

-7.46 (-2.57%)

06:31 Today Citi
Burlington Stores upgraded to Buy from Neutral at Citi
11/24/21 MKM Partners
Burlington Stores price target raised to $368 from $360 at MKM Partners
11/24/21 Deutsche Bank
Burlington Stores price target lowered to $316 from $364 at Deutsche Bank
11/23/21 MKM Partners
Buy Burlington Stores on any weakness, says MKM Partners
TJX TJX
$69.30 /

-2.2 (-3.08%)

06:32 Today Citi
TJX upgraded to Buy from Neutral at Citi
11/26/21 Argus
TJX price target raised to $88 from $86 at Argus
11/18/21 Loop Capital
TJX price target raised to $70 from $65 at Loop Capital
11/18/21 Morgan Stanley
TJX price target raised to $88, named as new top pick at Morgan Stanley
BURL Burlington Stores
$283.37 /

-7.46 (-2.57%)

TJX TJX
$69.30 /

-2.2 (-3.08%)

BURL Burlington Stores
$283.37 /

-7.46 (-2.57%)

TJX TJX
$69.30 /

-2.2 (-3.08%)

TJX TJX
$69.30 /

-2.2 (-3.08%)

Hot Stocks
Church & Dwight acquires TheraBreath brand for $580M » 06:40
11/29/21
11/29
06:40
11/29/21
06:40
CHD

Church & Dwight

$91.76 /

-1.615 (-1.73%)

Church & Dwight has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

11/01/21 Jefferies
Newell Brands remains a top long idea, says Jefferies
10/20/21 Deutsche Bank
Church & Dwight price target lowered to $90 from $94 at Deutsche Bank
07/14/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
07/13/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

CHD Church & Dwight
$91.76 /

-1.615 (-1.73%)

Hot Stocks
Cathie Wood's ARK Investment bought 317.3K shares of Exact Sciences on Friday  06:40
11/29/21
11/29
06:40
11/29/21
06:40
EXAS

Exact Sciences

$87.34 /

-0.83 (-0.94%)

 
ShowHide Related Items >><<
EXAS Exact Sciences
$87.34 /

-0.83 (-0.94%)

EXAS Exact Sciences
$87.34 /

-0.83 (-0.94%)

11/03/21 BTIG
Exact Sciences price target lowered to $120 from $145 at BTIG
11/03/21 Craig-Hallum
Exact Sciences price target lowered to $133 from $144 at Craig-Hallum
11/03/21 Raymond James
Exact Sciences downgraded to Outperform from Strong Buy at Raymond James
11/03/21 Wells Fargo
Exact Sciences price target lowered to $95 from $120 at Wells Fargo
EXAS Exact Sciences
$87.34 /

-0.83 (-0.94%)

EXAS Exact Sciences
$87.34 /

-0.83 (-0.94%)

EXAS Exact Sciences
$87.34 /

-0.83 (-0.94%)

General news
Oil Action: » 06:40
11/29/21
11/29
06:40
11/29/21
06:40
$ECON

Economic Data

/

+

Oil Action: Oil prices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.